FDA Inspection 717283 — Janssen Vaccines, Zweigniederlassung Der Cilag GmbH International
The FDA completed an inspection of Janssen Vaccines, Zweigniederlassung Der Cilag GmbH International on Feb 25, 2011 in Bern. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 25, 2011
- Fiscal Year
- 2011
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Bern (Switzerland)